Overview
The first book of its kind that brings together researchers from many different disciplines of neuroscience together to review the current state-of-the-art in EPO and the nervous system
Includes supplementary material: sn.pub/extras
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (13 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
Erythropoietin (EPO) is a chemokine hormone that is widely distributed throughout the body. In addition to its traditional role as a hormone that stimulates red blood cell production, in recent years many laboratories have shown that EPO can act as a neuroprotective compound in a variety of injury paradigms in the nervous system. Past experience with relatively safety profile of this FDA-approved drug makes it an ideal candidate to take it into clinical trials for neuroprotection. We are on the verge of major clinical trials using this drug for neuroprotection in diseases ranging from stroke, to transverse myelitis to chemotherapy-induced peripheral neuropathy. This is the first book of its kind that brings together researchers from many different disciplines of neuroscience to review the current state-of-the-art in EPO and the nervous system. This book will benefit scientists and clinicians interested in neuroprotection in the broadest sense.
Editors and Affiliations
Bibliographic Information
Book Title: Erythropoietin and the Nervous System
Editors: Ahmet Höke
DOI: https://doi.org/10.1007/978-0-387-30011-5
Publisher: Springer New York, NY
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer-Verlag US 2006
Hardcover ISBN: 978-0-387-30010-8Published: 29 November 2005
Softcover ISBN: 978-1-4899-7383-2Published: 19 November 2014
eBook ISBN: 978-0-387-30011-5Published: 28 September 2006
Edition Number: 1
Number of Pages: XI, 223
Topics: Neurology, Neurosciences, Psychiatry, Neurosurgery